Ralista 60mg Tablet

Ralista 60 mg Tablet is a prescription medicine that contains raloxifene, a selective estrogen receptor modulator (SERM). It is primarily prescribed for postmenopausal women to help prevent and treat osteoporosis (weakening of the bones) by mimicking the positive effects of estrogen on bone tissue. Importantly, raloxifene also lowers the risk of invasive breast cancer in postmenopausal women who are at high risk for the disease by blocking estrogen’s effects in breast tissue, which can reduce the chance that hormone‑responsive cancer cells will grow. While Ralista is not used to treat existing breast cancer, it is widely used as a preventive therapy to reduce the risk of developing estrogen receptor‑positive breast cancer in susceptible women.

The medication works by acting like estrogen in some parts of the body (such as bones) while blocking estrogen’s action in breast tissue, providing a dual benefit of bone protection and cancer risk reduction without stimulating the uterus. Before starting Ralista, consultation with a healthcare provider is essential because it may not be suitable for women with a history of blood clots, stroke, liver disease, or other serious conditions. Common side effects can include hot flashes, leg cramps, joint pain, and sweating, and more serious risks such as thromboembolism must be discussed with a doctor. Ralista is not recommended during pregnancy or breastfeeding, and its use is based on a careful evaluation of individual risk factors by a physician.